Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Withdrawn 2Recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Surgical Wound Infection 1Skin Neoplasms 1Neoplasms 1Inflammation 1Infections 1Genetic Predisposition to Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Cephalexin × Clear all
NCT05020574 2026-03-18

Microbiome and Association With Implant Infections

University of California, San Francisco

Phase 2 Recruiting
200 enrolled
Breast

Breast Neoplasms, Genetic Predisposition to Disease

NCT06207786 2024-11-25

Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery

Mayo Clinic

Phase NA Withdrawn
Dermatologic

Skin Neoplasms

NCT01899690 2017-02-24

Antibiotics and Tissue Expanders in Breast Reconstruction

Emory University

Phase 4 Withdrawn

Infections, Inflammation, Neoplasms, Surgical Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡